DGAP-Adhoc: RHÖN-KLINIKUM AG: Ad hoc-Notification

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-Adhoc: RHÖN-KLINIKUM AG: Ad hoc-Notification pursuant to Section 15 (1) of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG)

RHÖN-KLINIKUM AG / Key word(s): AGM/EGM/Miscellaneous 12.06.2014 21:38 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad hoc-Notification pursuant to Section 15 (1) of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG) Most Important Voting Results of the Annual General Meeting on 12 June 2014 The Annual General Meeting of RHÖN-KLINIKUM Aktiengesellschaft today resolved amongst others the following: 1. Item 2 of the agenda (Appropriation of profits by distribution of a dividend in the amount of EUR 0.25 per share and optionally a further dividend of EUR 12,08 per share only in the event that the share buyback according to TOP 3 is not made in time) was adopted by a majority of 99.88%. There were objections put on record of the minutes. 2. Item 3 of the agenda (Share repurchase for redemption and reduction of the share capital with a repurchase volume of EUR 1,669,972,834.19) was adopted by a majority of 99.35%. There were objections put on record of the minutes. A purchase offer will only be made after the resolution on the capital reduction has been entered into the commercial register, which may be delayed in case of legal actions against the resolution. If by the end of November 30, 2014 - in the case of legal actions against the resolution December 31, 2014 - no shares have been tendered in response to the purchase offer, the resolution lapses and the corresponding funds will be distributed as further dividend. Details such as repurchase price and tender ratio will be announced with the publication of the offer. 3. Item 4 of the agenda (Authorization to acquire further own shares in the amount of max. 10% of the relevant share capital) was adopted by a majority of 99.63%. There were objections put on record of the minutes. 4. The following members of the Supervisory Board proposed by the Supervisory Board were elected: Mr. Stephan Holzinger, Dr. Katrin Vernau, Mr. Reinhard Hartl, Professor Dr. hc Ludwig Georg Braun. There were objections put on record of the minutes. 5. Item 12 of the agenda (Abrogation of the 2013 Annual General Meeting's resolution for the abolition of the majority requirement of more than 90% for certain important resolutions of the annual general meeting) was rejected with a majority of 81.73%. There were objections put on record of the minutes. The details on the proposed resolutions and the voluntary report of the management board regarding the proposed resolutions described in Sections 1 and 3 above are available in the invitation to the Annual General Meeting 2014, which was published on 5 May 2014 in the Federal Gazette (Bundesanzeiger) and on the company's website. The complete resolution results will be published in accordance with section 130 (6) of the German Stock Corporation Act (Aktiengesetz) on the company's website. Contact: Dr. Kai G. Klinger Head of Investor Relations RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telefon: +49 (0) 9771 65-1318 Telefax: +49 (0) 9771 99-1736 E-Mail: ir@rhoen-klinikum-ag.com Achim Struchholz Head of Corporate Communications RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Telefon: +49 (0) 9771 65-1327 Telefax: +49 (0) 9771 65-1820 E-Mail: kommunikation@rhoen-klinikum-ag.com 12.06.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: rka@rhoen-klinikum-ag.com Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BICV Expands in Europe with Cutting-Edge Tech

Updated Category News Views 42

First Steps into Europe's Automotive Arena Alright, here's the scoop. BICV Technology Co., the Chinese titan in vehicle connectivity, is strutting their stuff at the International Suppliers Fair in Wolfsburg. This isn't a small-time fair, folks. It's one of Europe's biggest automotive supply gigs, showing off the latest in manufacturing and tech. BICV is there with over...

Continue Reading
Chedraui's Q3 '26 Balancing Act: Highlights and Hurdles

Updated Category News Views 79

Mexico's Retail Giant Battles Mixed Outcomes Wading through the latest quarterly scrimmage, Grupo Comercial Chedraui reports that the game plan hasn't changed—stick to low prices, varied assortments, and cracking customer experiences. But the scoreboard's got a few odd numbers, and depending on where you sit, the tally looks slightly uneven. Same Store Sales: A Regional...

Continue Reading
Ozelle's O-Cyte 1: Revolutionizing Hematology with AI

Updated Category News Views 129

O-Cyte 1 Leads the Charge at MEDICA 2026 With all the chatter floating around the latest whiz-bang healthcare technology, it's downright refreshing to stumble upon something as genuinely promising as Ozelle's O-Cyte 1. Slated to be the talk of the town at this year’s MEDICA in DÜSSELDORF, this shiny new automated hematology analyzer promises to marry the best of AI and...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 89

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 42

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
Hengrui Pharma: Innovating Oncology on Global Stage

Updated Category News Views 73

Setting the Global Stage for Chinese Pharmaceutical Innovation Ah, China is no longer just the factory of the world; it's rolling its sleeves up and getting deep into the pharma game. Hengrui Pharma, a heavyweight in China's pharmaceutical scene, just pulled off a commendable performance at the European Society for Medical Oncology (ESMO) Congress 2026 over in Madrid....

Continue Reading
York Space Systems Faces Turbulence Amid Investor Lawsuit

Updated Category News Views 46

York's Shaky Strategy Under the Microscope How do you go from sky-high ambitions to a grinding halt in a matter of weeks? This ain’t your typical Wall Street plot twist—it involves York Space Systems, or NYSE:YSS. These guys promised dominance in the Space Development Agency’s Transport Layer program, only to have their shooting star come crashing down. And now,...

Continue Reading
Caylent's Strategic Moves Gain Eyeballs in ISG Report

Updated Category News Views 65

Big Moves in the Contact Center Game There’s a buzz in the tech trenches, folks. Caylent just climbed onto the radar with its prominent mention in the 2026 ISG Provider Lens® Amazon Connect Ecosystem Report. Being dubbed a Product Challenger is no small feat when you’re pitted against some of the giants in tech. What’s their edge? An AI-first strategy, of course,...

Continue Reading
2021 Ferrari Portofino Shines Bright at Jake's Motorcars

Updated Category News Views 67

San Diego might be known for its sunny weather, but Jake's Motorcars just cranked the heat with a 2021 Ferrari Portofino that flaunts a special-ordered Mandarin Orange interior. Now, if that doesn't scream "look at me," I don't know what does. For those who aren't just dabbling in Ferraris but are downright obsessed, let's dig into what makes this sports car not just...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 19

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Cboe Global Markets Has Grown Over a Decade

Updated Category News Views 178

Understanding the Growth of Cboe Global Markets Cboe Global Markets has displayed remarkable performance in the stock market over the past decade. Specifically, the company has outperformed the market by an average of 2.96% annually, resulting in a substantial annual return of approximately 14.72%. Presently, its market capitalization stands at around $26.52 billion,...

Continue Reading
Oilstainlab Unleashes the HF-11: A New Era in Automotive Innovation

Updated Category News Views 414

Oilstainlab Unleashes the HF-11: A New Era in Automotive Innovation Oilstainlab, known for its playful and daring approach to car manufacturing, has once again transcended traditional automotive boundaries with their latest offering—the HF-11. This remarkable vehicle blends an alluring aesthetic with brain-numbing performance metrics that challenge what is possible....

Continue Reading
Nuwellis Inc (NUWE) Boosts Market Presence with New Patent

Updated Category News Views 145

Nuwellis Inc Sees Significant Share Price Surge On a remarkable Wednesday, shares of Nuwellis Inc (NUWE) experienced an astonishing rise as the company disclosed that it has secured an essential patent for its cutting-edge blood filtering technology. The exciting news led to a 161.2% surge in its stock price, marking a significant moment for investors and the medical...

Continue Reading
Transform Your Floors: Discover ReCoat Revolution's Services

Updated Category News Views 234

ReCoat Revolution: A New Era for Floor Refinishing ReCoat Revolution has emerged as a game-changer in the floor refinishing industry by offering a faster, cleaner alternative to traditional methods. Founded by Ryan Steele, this innovative business is dedicated to revitalizing floors with minimal disruption. The recent opening of its new location marks a significant...

Continue Reading
Exploring the Growth of Robotics System Integration Until 2028

Updated Category News Views 220

Market Insights into Robotics System Integration The global robotics system integration market is poised for significant expansion, with expectations of growing by USD 4.95 billion from 2024 to 2028. This rapid development is fueled by innovations in artificial intelligence, which are redefining the landscape of automation. Research shows that the market is anticipated to...

Continue Reading